Why slimming supplements are discouraged in clinical practice
Dr. Nathalie Rousseau practises as a dietitian-nutritionist specialising in micronutrition with a university diploma from Paris VII. For 12 years, her position in practice has been consistent: do not recommend slimming supplements. "Either they were under-dosed, or the claims were not enforceable, or the cited studies were funded by the manufacturers themselves. The signal-to-noise ratio in slimming nutraceuticals is catastrophic."
What LIPOSLIM™ does differently
"LIPOSLIM™ is the first mass-market product I have seen with glucomannan at 3,176 mg (above the EFSA threshold of 3 g), chromium at 198 µg (5× the NRV, 2 EFSA claims) and piperine bio-enhancement across all actives. This is serious formulation work." Dr. Rousseau also notes the MORNING/EVENING architecture: "The separation of thermogenic (morning) and metabolic (evening) actives is consistent with what we know about nutritional chronobiology. The body does not have the same needs at 8am and 8pm. A product that ignores this is a product that doesn't understand pharmacokinetics."
Clinical limits and precautions
Dr. Rousseau tempers her positive view with the usual clinical precautions: "LIPOSLIM™ should not be recommended to pregnant or breastfeeding women, to people on anticoagulants (possible interaction with piperine and chromium), or to diabetics on hypoglycaemic medication without medical advice (chromium may potentiate the effect). Chromium at 198 µg remains within documented safety limits, but drug interactions must be assessed case by case." She concludes: "If a patient asks me for a slimming supplement, it is now the only one I can recommend in good conscience."